MedTrace Logo

Arteriopathy and Endothelial Function

NCT00487617 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2009-02-25

No results posted yet for this study

Summary

To determine whether fruit juice might reverse endothelial dysfunction and whether this reversibility has a prognosis value

Conditions

  • Peripheral Arterial Disease

Interventions

PROCEDURE

Fruit juice or placebo absorption

absorption of 300 ml of fruit juice ; 24 hours later, absorption of 300 ml of placebo.

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Principal Investigators

  • Olivier Rouyer, MD · Hôpitaux Universitaires de Strasbourg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2011-10-31
Completion
2012-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00487617 on ClinicalTrials.gov